Interplan is the appointed PCO for the 60th ERA Congress and the first point of contact with regard to the exhibition and sponsoring related questions.
Congress, Meeting & Event Management AG
Landsberger Str. 155
80687, Munich, Germany
AIFA (Italian Medicines Agency) Congresses and Meeting in Italy
In Italy congresses and meetings on topics related to the use of pharmaceuticals are governed by Article 124 of Legislative Decree 24 April 2006, N 219 (The Decree).
As per Italian law, the AIFA authorization is necessary
- for each pharmaceutical company (with Marketing Authorization Holder or the companies responsible for the actual marketing of pharmaceutical products) sponsoring the congress on topics in any way related to the use of its own pharmaceutical products.
the AIFA authorization is not necessary
- when a company promotes by advertising only medical devices or food supplements during a congress (products without Marketing Authorization)
- when a company sponsors a meeting about topics not related to the use of any of its own medicinal products; in this case the company is not allowed to expose or distribute any kind of advertising material during the meeting (Section 9 art. 124 D.L. n.219/06)
In Italy, any pharmaceutical company that sponsors a congress on topics related to the use of its pharmaceutical products, must submit an application to the competent unit of the Italian Medicines Agency (AIFA) to obtain a specific authorization. If your pharmaceutical company has a marketing authorization (MAH or AIC) in Italy or the companies responsible for the effective marketing of your pharmaceutical products and sponsor the congress on topics related to the use of your pharmaceutical products, you should contact Atlante Viaggi communicating your SIS code, by March 31, 2023: firstname.lastname@example.org
Atlante Viaggi Italia Srl
Via Bandello, 1
20123, Milan, Italy
ATLANTE VIAGGI ITALIA has been delegated by ERA 2023 to collect all applications and submit them to AIFA for authorization.